Brief: Revelation Biosciences Inc Completes Database Lock For Its Phase 1B Clear Clinical Study For The Treatment Of Allergic Rhinitis

Revelation Biosciences

14/07/2022 14:47

July 14 (Reuters) - Revelation Biosciences Inc  REVB.O :
    * REVELATION BIOSCIENCES INC. COMPLETES DATABASE LOCK FOR
ITS
PHASE 1B CLEAR CLINICAL STUDY OF REVTX-99B FOR THE TREATMENT OF
ALLERGIC RHINITIS

Source text for Eikon:  ID:nGNX7q5mwy 
Further company coverage:  REVB.O